Invention Grant
- Patent Title: Fused heterocyclic derivatives and methods of use
-
Application No.: US13309488Application Date: 2011-12-01
-
Publication No.: US08524900B2Publication Date: 2013-09-03
- Inventor: Brian K. Albrecht , David Bauer , Christiane M. Bode , Shon Booker , Alessandro Boezio , Deborah Choquette , Derin D'Amico , Jean-Christophe Harmange , Satoko Hirai , Richard T. Lewis , Longbin Liu , Julia Lohman , Mark H. Norman , Michele Potashman , Aaron C. Siegmund , Stephanie K. Springer , Markian Stec , Ning Xi , Kevin Yang
- Applicant: Brian K. Albrecht , David Bauer , Christiane M. Bode , Shon Booker , Alessandro Boezio , Deborah Choquette , Derin D'Amico , Jean-Christophe Harmange , Satoko Hirai , Richard T. Lewis , Longbin Liu , Julia Lohman , Mark H. Norman , Michele Potashman , Aaron C. Siegmund , Stephanie K. Springer , Markian Stec , Ning Xi , Kevin Yang
- Applicant Address: US CA Thousand Oaks
- Assignee: Amgen Inc.
- Current Assignee: Amgen Inc.
- Current Assignee Address: US CA Thousand Oaks
- Agent Olga Mekhovich
- Main IPC: C07D487/04
- IPC: C07D487/04 ; C07D403/12 ; C07D403/14 ; C07D401/12 ; C07D401/14 ; C07D413/14 ; A61K31/5025 ; A61K31/4353 ; A61K31/4523 ; A61P35/00
Abstract:
Selected compounds are effective for prophylaxis and treatment of diseases, such as HGF mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.
Public/Granted literature
- US20120148531A1 FUSED HETEROCYCLIC DERIVATIVES AND METHODS OF USE Public/Granted day:2012-06-14
Information query
